Skip to content

Daniel Garza, MD

NPI 1407936321ActiveIndividual· Psychiatry & Neurology, Addiction Medicine· New York, NY

Opted out of Medicare from January 2018 to January 2028. Psychiatry & Neurology, Addiction Medicine (MD) in New York, New York, licensed in NY, with an NPI issued in October 2006. Part D covered 84 prescriptions written in 2024, 98% of them generic.

Overview

NPI1407936321
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedOct 16, 2006
Last updated in NPPESJul 31, 2019

Specialties and licenses

TaxonomyCodeLicenseState
Psychiatry & Neurology, Addiction Medicine Primary2084A0401X185883NY

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026
Opt-outOpted out Jan 31, 2018 – Jan 31, 2028
Can order and referYes

During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.

Part D prescriptions in 2024

Prescriptions (claims)84 · 126 30-day fills
Total drug cost$1,343
Generic share98% of claims

Medicare sources and data years

Industry payments (Open Payments)

None reported for 2025 or 2024.

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Psychiatry & Neurology, Addiction Medicine providers in New York

All Psychiatry & Neurology, Addiction Medicine providers in New York →